Aethlon Medical corrects Rossetti holdings to 24,222

The RSUs vest in four equal quarterly installments from June 30, 2026, through March 31, 2027, subject to continued service on each date.

This filing corrects an earlier one, and you can read the original Form 4 if you want to see what changed.

Rhea-AI Filing Summary

Aethlon Medical (AEMD) director Angela Rossetti received a grant of 21,815 RSUs on April 17, 2026; the transaction reports $2.29 per share. The RSUs vest in four equal quarterly installments on June 30, 2026, September 30, 2026, December 31, 2026, and March 31, 2027, subject to continued service on each date. The amendment corrects her post-transaction beneficially owned share count to 24,222 shares, rather than the 26,207 shares previously shown, to account for Aethlon Medical’s recent reverse stock split.

Insider Trade Summary

Grant/Award: 21,815 shares

Grant/Award 1 txn

Insider Rossetti Angela

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1, F2	21,815	$2.29	$50K

Holdings After Transaction: Common Stock — 4,846 shares (Direct)

Footnotes (2)

1. F1. The Reporting Person was granted RSUs that vest in four equal quarterly installments on each of June 30, 2026, September 30, 2026, December 31, 2026 and March 31, 2027, subject to the Reporting Person's continued service with the Company on each such vesting date.
2. F2. The amount of securities beneficially owned is being amended to account for a typographical error in the Form 4 filed on April 21, 2026. The number of shares beneficially owned following the reported transaction was shown as 26,207 shares, but should have been 24,222. This number accounts for Aethlon's recent reverse stock split.

Key Figures

RSUs granted: 21,815 RSUs Reported price per share: $2.29 per share Post-transaction beneficially owned shares: 24,222 shares +1 more

4 metrics

RSUs granted 21,815 RSUs April 17, 2026

Reported price per share $2.29 per share Grant reported for April 17, 2026

Post-transaction beneficially owned shares 24,222 shares Corrected by the amendment

Vesting installments 4 equal quarterly installments June 30, 2026, September 30, 2026, December 31, 2026, and March 31, 2027

Key Terms

RSUs, quarterly installments, beneficially owned, reverse stock split

4 terms

RSUs financial

"granted RSUs that vest in four equal quarterly installments"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

quarterly installments financial

"vest in four equal quarterly installments"

beneficially owned financial

"The amount of securities beneficially owned"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

reverse stock split technical

"Aethlon's recent reverse stock split"

A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many RSUs did Aethlon Medical (AEMD) director Angela Rossetti receive?

Angela Rossetti was granted 21,815 RSUs on April 17, 2026, with a reported price of $2.29 per share. The award vests in four equal quarterly installments, subject to continued service on each vesting date.

What was Angela Rossetti’s corrected AEMD shareholding after the award?

The amended post-transaction beneficially owned share count is 24,222 shares. It corrects the 26,207 shares shown in the April 21, 2026 Form 4 to account for Aethlon Medical’s recent reverse stock split.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/15/2026 - 12:50 PM EDT Accepted by SEC EDGAR 10/15/2026 - 12:49 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rossetti Angela

(Last) (First) (Middle)

11555 SORRENTO VALLEY ROAD, STE 203

(Street)

SAN DIEGO CALIFORNIA 92121

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AETHLON MEDICAL INC [ AEMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
04/21/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/17/2026		A		21,815(1)	A	$2.29	4,846(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Reporting Person was granted RSUs that vest in four equal quarterly installments on each of June 30, 2026, September 30, 2026, December 31, 2026 and March 31, 2027, subject to the Reporting Person's continued service with the Company on each such vesting date.

2. The amount of securities beneficially owned is being amended to account for a typographical error in the Form 4 filed on April 21, 2026. The number of shares beneficially owned following the reported transaction was shown as 26,207 shares, but should have been 24,222. This number accounts for Aethlon's recent reverse stock split.

	/s/ Angela Rossetti by: James B. Frakes, Attorney-in-fact	10/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)